ROD1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.67033054054855E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.34999997028984E-09 |
Normal-vs-Stage2 |
5.953600E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
3.818900E-03 |
Stage1-vs-Stage2 |
5.911400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
1.447600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.691200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.46498435183685E-12 |
Normal-vs-AfricanAmerican |
1.431770E-01 |
Normal-vs-Asian |
5.397600E-02 |
Caucasian-vs-AfricanAmerican |
1.290190E-01 |
Caucasian-vs-Asian |
3.223200E-01 |
AfricanAmerican-vs-Asian |
6.069400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.60209999999972E-05 |
Normal-vs-Female |
1.65710001276409E-10 |
Male-vs-Female |
5.013800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.815600E-03 |
Normal-vs-Extreme_Weight |
2.16569999711425E-08 |
Normal-vs-Obese |
1.322760E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.853600E-01 |
Normal_Weight-vs-Obese |
1.358190E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.684950E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.058380E-01 |
Normal-vs-Age(41-60Yrs) |
1.002260E-04 |
Normal-vs-Age(61-80Yrs) |
6.26039997619898E-09 |
Normal-vs-Age(81-100Yrs) |
4.192400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.515390E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.126600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.767420E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.767600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.650200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.805990E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
8.983800E-01 |
Normal-vs-Grade 3 |
8.323000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
4.643200E-01 |
Grade 2-vs-Grade 4 |
8.983800E-01 |
Grade 3-vs-Grade 4 |
8.323000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.73330305242825E-11 |
Normal-vs-N1 |
1.339290E-03 |
N0-vs-N1 |
5.995100E-03 |
|
|